$LOXO Loxo Oncology, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Loxo Oncology, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Loxo Oncology, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Loxo Oncology, Inc. for free.
IRS Number: 462996673
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: LOXO
Company Address: 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD 06901
Phone number: 203-658-4749
Market Capitalization: $860.18M
Prev close: $39.70
Average Daily Volume: 258,558
Days Low: $39.05
Year Low: $16.50
Year High: $41.36
Loxo Oncology, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Operating Off ... | Option Exercise | D | 139.77 | 57,000 | 7,966,890 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Operating Off ... | Option Exercise | D | 84.88 | 200,000 | 16,976,000 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Operating Off ... | Option Exercise | D | 43.56 | 35,000 | 1,524,600 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Operating Off ... | Option Exercise | D | 26.27 | 74,000 | 1,943,980 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Operating Off ... | Option Exercise | D | 31.69 | 43,000 | 1,362,670 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Operating Off ... | Option Exercise | D | 13.67 | 78,943 | 1,079,151 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Operating Off ... | Option Exercise | D | 3.65 | 35,026 | 127,775 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Operating Off ... | Sell | D | 235.00 | 19,000 | 4,465,000 | 0 | 19 K to 0 (-100.00 %) |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Nanda Nisha | Chief Development O ... | Option Exercise | D | 139.77 | 37,000 | 5,171,490 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Nanda Nisha | Chief Development O ... | Option Exercise | D | 84.88 | 75,000 | 6,366,000 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Nanda Nisha | Chief Development O ... | Option Exercise | D | 43.56 | 12,000 | 522,720 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Nanda Nisha | Chief Development O ... | Option Exercise | D | 26.27 | 18,375 | 482,711 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Nanda Nisha | Chief Development O ... | Option Exercise | D | 27.00 | 14,870 | 401,490 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Nanda Nisha | Chief Development O ... | Option Exercise | D | 31.69 | 9,228 | 292,435 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Nanda Nisha | Chief Development O ... | Option Exercise | D | 13.67 | 10,861 | 148,470 | 0 |